triamcinolone acetonide has been researched along with salmeterol xinafoate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Baraniuk, J; Berger, WE; Edwards, LD; Johnson, M; Murray, JJ; Nathan, RA; Rickard, KA; Srebro, S | 1 |
| Lipworth, BJ | 1 |
| Dorinsky, PM; Poinsett-Holmes, K; Stoloff, S | 1 |
| Boushey, HA; Fahy, JV; Kraft, M; Lazarus, SC; Lemanske, RF; Martin, RJ; Szefler, SJ | 1 |
| Larson, I; Morton, DA; Qu, L; Stewart, PJ; Zhou, QT | 1 |
1 review(s) available for triamcinolone acetonide and salmeterol xinafoate
| Article | Year |
|---|---|
Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Cost-Benefit Analysis; Drug Therapy, Combination; Fluticasone; Humans; Leukotriene Antagonists; Salmeterol Xinafoate; Triamcinolone Acetonide | 2002 |
3 trial(s) available for triamcinolone acetonide and salmeterol xinafoate
| Article | Year |
|---|---|
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Topics: Administration, Inhalation; Administration, Topical; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Sleep; Triamcinolone Acetonide | 1999 |
Use of fluticasone in asthma.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bias; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluticasone; Humans; Research Design; Salmeterol Xinafoate; Triamcinolone Acetonide | 2000 |
Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cell Count; Double-Blind Method; Female; Humans; Inflammation Mediators; Male; Mast Cells; Salmeterol Xinafoate; Serine Endopeptidases; Time Factors; Treatment Failure; Triamcinolone Acetonide; Tryptases | 2003 |
2 other study(ies) available for triamcinolone acetonide and salmeterol xinafoate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach.
Topics: Administration, Inhalation; Aerosols; Albuterol; Chemistry, Pharmaceutical; Excipients; Nebulizers and Vaporizers; Particle Size; Powders; Salmeterol Xinafoate; Stearic Acids; Triamcinolone Acetonide | 2010 |